Literature DB >> 23475622

Altered expression of SIRT gene family in head and neck squamous cell carcinoma.

Chi-Chih Lai1, Pai-Mei Lin, Sheng-Fung Lin, Cheng-Hsien Hsu, Hsin-Ching Lin, Ming-Luen Hu, Cheng-Ming Hsu, Ming-Yu Yang.   

Abstract

Head and neck squamous cell carcinoma (HNSCC) include a group of malignant neoplasms that arise from the upper aerodigestive tract and represent the seventh most common cause of cancer-related death. The overall 5-year survival rates have not significantly improved for decades in spite of the advances in the field of oncology and surgery, encouraging further research on factors that might modify disease prognosis. The silent information regulator (SIR) genes (Sirtuins) play key roles in cellular stress and are associated with aging-related diseases including cancer. Currently, seven human sirtuin (SIRT1-7) genes have been identified, but the roles of SIRT genes in HNSCC are still uncertain. Therefore, in this study, we used real-time quantitative reverse transcription-polymerase chain reaction to investigate the expressions of the seven SIRT genes in human HNSCC tissues to assess the changes in cancerous and noncancerous parts and the correlation with different tumor behaviors. Our results demonstrated that the expression levels of SIRT1, SIRT2, SIRT3, SIRT5, SIRT6, and SIRT7 were significantly downregulated in cancerous tissues compared with noncancerous tissues (all p<0.01). The expression levels of SIRT1, SIRT2, SIRT3, SIRT5, and SIRT7 showed downregulation in advanced stages in respect to early stages (p<0.05). These results indicate that the downregulation of SIRT genes expression may contribute to the development of cancer and trigger the neoplastic disease to more advanced stages. Our study indicates that SIRT genes expression could help in the diagnosis and represent a prognostic biomarker in HNSCC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23475622     DOI: 10.1007/s13277-013-0726-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  36 in total

Review 1.  Habitual risk factors for head and neck cancer.

Authors:  David Goldenberg; Juna Lee; Wayne M Koch; Michael M Kim; Barry Trink; David Sidransky; Chul-So Moon
Journal:  Otolaryngol Head Neck Surg       Date:  2004-12       Impact factor: 3.497

2.  Genomic instability and aging-like phenotype in the absence of mammalian SIRT6.

Authors:  Raul Mostoslavsky; Katrin F Chua; David B Lombard; Wendy W Pang; Miriam R Fischer; Lionel Gellon; Pingfang Liu; Gustavo Mostoslavsky; Sonia Franco; Michael M Murphy; Kevin D Mills; Parin Patel; Joyce T Hsu; Andrew L Hong; Ethan Ford; Hwei-Ling Cheng; Caitlin Kennedy; Nomeli Nunez; Roderick Bronson; David Frendewey; Wojtek Auerbach; David Valenzuela; Margaret Karow; Michael O Hottiger; Stephen Hursting; J Carl Barrett; Leonard Guarente; Richard Mulligan; Bruce Demple; George D Yancopoulos; Frederick W Alt
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

Review 3.  Head and neck cancer-part 1: epidemiology, presentation, and preservation.

Authors:  H Mehanna; V Paleri; C M L West; C Nutting
Journal:  Clin Otolaryngol       Date:  2011-02       Impact factor: 2.597

Review 4.  SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis.

Authors:  Hidetaka Ota; Masato Eto; Sumito Ogawa; Katsuya Iijima; Masahiro Akishita; Yasuyoshi Ouchi
Journal:  J Atheroscler Thromb       Date:  2010-03-09       Impact factor: 4.928

5.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

6.  Clinicopathological parameters and outcome of 245 patients operated for oral squamous cell carcinoma.

Authors:  Paolo Garzino-Demo; Alessandro Dell'Acqua; Paola Dalmasso; Massimo Fasolis; Gian Marco La Terra Maggiore; Guglielmo Ramieri; Sid Berrone; Monica Rampino; Marina Schena
Journal:  J Craniomaxillofac Surg       Date:  2006-07-21       Impact factor: 2.078

7.  GCIP/CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis.

Authors:  Wenbin Ma; Lewis J Stafford; Dali Li; Jian Luo; Xiaoying Li; Guang Ning; Mingyao Liu
Journal:  J Cell Biochem       Date:  2007-04-15       Impact factor: 4.429

8.  SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin.

Authors:  Eriko Michishita; Ronald A McCord; Elisabeth Berber; Mitomu Kioi; Hesed Padilla-Nash; Mara Damian; Peggie Cheung; Rika Kusumoto; Tiara L A Kawahara; J Carl Barrett; Howard Y Chang; Vilhelm A Bohr; Thomas Ried; Or Gozani; Katrin F Chua
Journal:  Nature       Date:  2008-03-12       Impact factor: 49.962

Review 9.  Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence.

Authors:  Diego Albani; Letizia Polito; Gianluigi Forloni
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 10.  SIRT1, is it a tumor promoter or tumor suppressor?

Authors:  Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2009-01-21       Impact factor: 6.580

View more
  53 in total

1.  When Anti-Aging Studies Meet Cancer Chemoprevention: Can Anti-Aging Agent Kill Two Birds with One Blow?

Authors:  Noriko N Yokoyama; Andria Denmon; Edward M Uchio; Mark Jordan; Dan Mercola; Xiaolin Zi
Journal:  Curr Pharmacol Rep       Date:  2015-04-14

2.  Tissue-specific gene expression and fasting regulation of sirtuin family in gilthead sea bream (Sparus aurata).

Authors:  Paula Simó-Mirabet; Azucena Bermejo-Nogales; Josep Alvar Calduch-Giner; Jaume Pérez-Sánchez
Journal:  J Comp Physiol B       Date:  2016-07-18       Impact factor: 2.200

3.  Regulation of Serine-Threonine Kinase Akt Activation by NAD+-Dependent Deacetylase SIRT7.

Authors:  Jia Yu; Bo Qin; Fengying Wu; Sisi Qin; Somaira Nowsheen; Shan Shan; Jacqueline Zayas; Huadong Pei; Zhenkun Lou; Liewei Wang
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

4.  Emerging Roles for SIRT5 in Metabolism and Cancer.

Authors:  Lauren R Bringman-Rodenbarger; Angela H Guo; Costas A Lyssiotis; David B Lombard
Journal:  Antioxid Redox Signal       Date:  2017-10-26       Impact factor: 8.401

5.  High expression of Sirt7 served as a predictor of adverse outcome in breast cancer.

Authors:  Qian Geng; Haoyu Peng; Fengsheng Chen; Rongcheng Luo; Rong Li
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 6.  SIRT6, a Mammalian Deacylase with Multitasking Abilities.

Authors:  Andrew R Chang; Christina M Ferrer; Raul Mostoslavsky
Journal:  Physiol Rev       Date:  2019-08-22       Impact factor: 37.312

7.  SIRT6 inhibits colorectal cancer stem cell proliferation by targeting CDC25A.

Authors:  Wenguang Liu; Manwu Wu; Hechun Du; Xiaoliang Shi; Tao Zhang; Jie Li
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

Review 8.  Chromatin and beyond: the multitasking roles for SIRT6.

Authors:  Sita Kugel; Raul Mostoslavsky
Journal:  Trends Biochem Sci       Date:  2014-01-14       Impact factor: 13.807

9.  Sirtuin 7-mediated deacetylation of WD repeat domain 77 (WDR77) suppresses cancer cell growth by reducing WDR77/PRMT5 transmethylase complex activity.

Authors:  Hao Qi; Xiaoyan Shi; Miao Yu; Boya Liu; Minghui Liu; Shi Song; Shuaiyi Chen; Junhua Zou; Wei-Guo Zhu; Jianyuan Luo
Journal:  J Biol Chem       Date:  2018-10-03       Impact factor: 5.157

Review 10.  Mitochondrial Sirtuins in Cancer: Emerging Roles and Therapeutic Potential.

Authors:  Jasmine George; Nihal Ahmad
Journal:  Cancer Res       Date:  2016-04-20       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.